Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
May 9, 2025
New Executive Order Promotes Domestic Production of Critical Medicines
April 4, 2025
FDA's LDT Rule Struck Down by Court: FDA Has Lost the Battle, But Is the War Over?
January 13, 2025
FDA Finalizes Guidance on Scientific Information on Unapproved Uses (SIUU)
May 12, 2025
Former GE Healthcare, Fresenius Litigation & Compliance Leader Pat Murphy Joins King & Spalding in Washington, D.C.
May 2, 2025
K&S advises Novo Nordisk before the Second Circuit in case defending dismissal of antitrust claims
April 21, 2025
King & Spalding Secures Another Defense Jury Verdict for Johnson & Johnson in Cosmetic Talcum Powder Litigation